You've probably seen cannabis products marketed as "immune support." But what's actually happening when cannabinoids ...
Company continues to advance an innovative pipeline of NKT cell regulators for the treatment of high-value inflammatory, fibrotic and autoimmune diseases LA JOLLA, CA, Sept. 30, 2024 (GLOBE NEWSWIRE) ...
IND filing to support clinical development of ANB101 in autoimmune and inflammatory diseases expected in H2 2024 Reiterating year-end 2023 cash and investments of $400 to $410 million and cash runway ...
EQ504 has a unique, multi-modal, non-immunosuppressive mechanism of action that is complementary to other immuno-inflammatory therapeutics EQ504 data to be presented in three poster presentations next ...
GRI Bio, Inc., a biotechnology company focused on developing Natural Killer T cell modulators for inflammatory, fibrotic, and autoimmune diseases, announced that it has regained compliance with Nasdaq ...
“We’re witnessing a renaissance in cytokine targeting,” says Dr. Emily Rhodes, immunologist at the Stanford Institute for Translational Medicine. “And TNF-α is still the most contested—and the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback